Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Analysis of exhaled breath for disease detection.

Amann A, Miekisch W, Schubert J, Buszewski B, Ligor T, Jezierski T, Pleil J, Risby T.

Annu Rev Anal Chem (Palo Alto Calif). 2014;7:455-82. doi: 10.1146/annurev-anchem-071213-020043. Review.

PMID:
25014347
2.

Noninvasive detection of lung cancer by analysis of exhaled breath.

Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A.

BMC Cancer. 2009 Sep 29;9:348. doi: 10.1186/1471-2407-9-348.

3.

Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath.

Beauchamp J.

J Breath Res. 2011 Sep;5(3):037103. doi: 10.1088/1752-7155/5/3/037103. Epub 2011 Jun 7. Review.

PMID:
21654021
4.

Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.

Dallinga JW, Smolinska A, van Schooten FJ.

Methods Mol Biol. 2014;1198:251-63. doi: 10.1007/978-1-4939-1258-2_16.

PMID:
25270934
5.

Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.

van Mastrigt E, Reyes-Reyes A, Brand K, Bhattacharya N, Urbach HP, Stubbs AP, de Jongste JC, Pijnenburg MW.

J Breath Res. 2016 Apr 8;10(2):026003. doi: 10.1088/1752-7155/10/2/026003.

PMID:
27058305
6.

Potential of Mass Spectrometry in Developing Clinical Laboratory Biomarkers of Nonvolatiles in Exhaled Breath.

Beck O, Olin AC, Mirgorodskaya E.

Clin Chem. 2016 Jan;62(1):84-91. doi: 10.1373/clinchem.2015.239285. Epub 2015 Nov 17. Review.

7.

The identification of hypoxia biomarkers from exhaled breath under normobaric conditions.

Harshman SW, Geier BA, Fan M, Rinehardt S, Watts BS, Drummond LA, Preti G, Phillips JB, Ott DK, Grigsby CC.

J Breath Res. 2015 Oct 27;9(4):047103. doi: 10.1088/1752-7155/9/4/047103.

PMID:
26505091
8.

Mass spectrometry for real-time quantitative breath analysis.

Smith D, Španěl P, Herbig J, Beauchamp J.

J Breath Res. 2014 Jun;8(2):027101. doi: 10.1088/1752-7155/8/2/027101. Epub 2014 Mar 28. Review.

PMID:
24682047
9.

The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.

Amann A, Costello Bde L, Miekisch W, Schubert J, Buszewski B, Pleil J, Ratcliffe N, Risby T.

J Breath Res. 2014 Sep;8(3):034001. doi: 10.1088/1752-7155/8/3/034001. Epub 2014 Jun 19. Review.

PMID:
24946087
10.

Human exhaled air analytics: biomarkers of diseases.

Buszewski B, Kesy M, Ligor T, Amann A.

Biomed Chromatogr. 2007 Jun;21(6):553-66. Review.

PMID:
17431933
11.

Exhaled breath condensate biomarkers in COPD.

Borrill ZL, Roy K, Singh D.

Eur Respir J. 2008 Aug;32(2):472-86. doi: 10.1183/09031936.00116107. Review.

12.
13.

Breath biomarkers in environmental health science: exploring patterns in the human exposome.

Pleil JD, Stiegel MA, Sobus JR.

J Breath Res. 2011 Dec;5(4):046005. doi: 10.1088/1752-7155/5/4/046005. Epub 2011 Sep 9. Review.

PMID:
21904020
14.

Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.

Purkhart R, Köhler H, Liebler-Tenorio E, Meyer M, Becher G, Kikowatz A, Reinhold P.

J Breath Res. 2011 Jun;5(2):027103. doi: 10.1088/1752-7155/5/2/027103. Epub 2011 Apr 21.

PMID:
21512209
15.

Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds.

Basanta M, Ibrahim B, Douce D, Morris M, Woodcock A, Fowler SJ.

J Breath Res. 2012 Jun;6(2):026002. doi: 10.1088/1752-7155/6/2/026002. Epub 2012 May 2.

PMID:
22549110
16.

Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury.

Bos LD, van Walree IC, Kolk AH, Janssen HG, Sterk PJ, Schultz MJ.

J Appl Physiol (1985). 2013 Nov;115(10):1487-95. doi: 10.1152/japplphysiol.00685.2013. Epub 2013 Aug 1.

17.

Exhaled biomarkers.

Kharitonov SA, Barnes PJ.

Chest. 2006 Nov;130(5):1541-6. Review.

PMID:
17099035
18.

Diagnosing lung cancer in exhaled breath using gold nanoparticles.

Peng G, Tisch U, Adams O, Hakim M, Shehada N, Broza YY, Billan S, Abdah-Bortnyak R, Kuten A, Haick H.

Nat Nanotechnol. 2009 Oct;4(10):669-73. doi: 10.1038/nnano.2009.235. Epub 2009 Aug 30.

PMID:
19809459
19.

In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.

Nizio KD, Perrault KA, Troobnikoff AN, Ueland M, Shoma S, Iredell JR, Middleton PG, Forbes SL.

J Breath Res. 2016 Apr 27;10(2):026008. doi: 10.1088/1752-7155/10/2/026008.

PMID:
27120170
20.

Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.

Meyer N, Dallinga JW, Nuss SJ, Moonen EJ, van Berkel JJ, Akdis C, van Schooten FJ, Menz G.

Respir Res. 2014 Nov 28;15:136. doi: 10.1186/s12931-014-0136-8.

Supplemental Content

Support Center